Skip to the main content.

Outcome-Driven Solutions for Medtech Challenges

Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.

Purpose-built solutions. Proven results. User & Patient-centered innovation.

 

Purpose-Built for Breakthroughs

Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity.  Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.  

We are the Innovation CRO.

Legacy of excellence. Proven execution. Patient impact accelerated.

 

Veranex Blog

5 min read

Artificial Intelligence (AI), General Data Protection Regulation (GDPR) and Cybersecurity: 10 Misconceptions About Medical Device Software

Medical Device Software (MDSW) is a growing, fast-evolving industry. However, manufacturers must often face a regulatory framework which does not evolve at the same speed. Regulation for medical devices is restrictive, since it needs to guarantee...

Read More

2 min read

Prioritizing Patient Safety and Fostering Innovation with the MHRAs New Roadmap for Medical Devices

On January 9, the United Kingdom (UK)’s Medicines and Healthcare Products Regulatory Agency (MHRA) released a regulatory framework – Roadmap towards...

Read More

4 min read

Strategies for Successful Clinical Data Management Rescue Studies

What is a rescue study? A rescue study is a clinical trial that is being conducted by a new vendor after having previously been conducted by another...

Read More

2 min read

Implications of FDA’s Quality Management System Regulation (QMSR) Final Rule

On February 2, 2024, the Food and Drug Administration (FDA) issued a final rule to amend the device current good manufacturing practice (CGMP)...

Read More

2 min read

New Proposal for Extended Transition Periods for IVDs: Can Manufacturers Slow Down Transition Efforts? 

On 23 January 2024, the EU Commission published a new proposal for amending the regulations EU 2017/745 (MDR) and EU 2017/746 (IVDR) aiming to...

Read More

2 min read

Key Insights from NMPA Guidance Draft 01 & 02 from Our Human Factors Team

The human factors team at Veranex has reviewed the NMPA Guidance Draft 01 and Draft 02 and submitted feedback to the agency. We’re committed to...

Read More

5 min read

Nanomaterials in Medical Devices: Biological Risks and Methodology for Biocompatibility Assessment

Introduction Nanomaterials, tiny scientific wonders that are invisible to the naked eye, hold the potential to revolutionize numerous facets of our...

Read More

5 min read

Challenges for Medical Device Database Builds and Strategies to Overcome Them

What are some of the challenges with database builds for medical device studies, given the current regulatory requirements? What are the important...

Read More

5 min read

Biocompatibility of Medical Devices: Process, Detailed Steps and 7 Hot Topics to Crack the Code of Medical Device Safety

The landscape of modern healthcare has been completely transformed by the development of cutting-edge medical devices. From life-saving implants to...

Read More